BioPharm International-12-02-2006

The Scottish Stem Cell Network brings together the entire stem-cell community in Scotland.

R&D spending in Scotland is forecasted to increase dramatically over the next few years.

Professors Walter Kolch, Ijeoma Uchegbu, and Anna Dominiczak are examples of scientists who have discovered a collaborative environment in the Scottish life sciences sector.

Individually, each of these strengths is significant. Together, they constitute a compelling proposition.

The life sciences industry continues to move at an astonishing pace. Covering biotechnology, healthcare, pharmaceuticals, informatics, tools, instrumentation, and device companies, the sector draws from a vast, multidisciplinary array of technologies including optical, software, engineering, electronics, and nanotechnology.

Scotland is a recognized leader in stem cell research, neuroscience, cancer research, genomics, proteomics, and bioinformatics.

The University of Dundee and the Scottish Crop Research Institute combined attract more than $95 million in research and commercial income annually.

Unlike other translational medicine research projects, this collaboration aims to study a wide range of diseases across the life sciences spectrum.

International partnerships, an attractive regulatory environment, and robust funding make Scotland a world leader in biotechnology.